Skip to main
CL
CL logo

Colgate-Palmolive (CL) Stock Forecast & Price Target

Colgate-Palmolive (CL) Analyst Ratings

Based on 28 analyst ratings
Buy
Strong Buy 29%
Buy 29%
Hold 36%
Sell 4%
Strong Sell 4%

Bulls say

Colgate-Palmolive has demonstrated strong organic sales growth, particularly in China, achieving high-single digits and bolstering an overall 4.3% growth for the quarter, driven by a combination of volume and pricing increases. The company's gross margin also saw a year-over-year increase of 70 basis points to 60.3%, supported by cost savings initiatives and pricing strategies, despite challenges from rising raw material costs. With significant market share gains in key categories and a reinforced focus on international expansion, the company is positioned to meet or exceed its long-term sales growth targets.

Bears say

Colgate-Palmolive's recent performance reveals a troubling trend, as the company's organic sales growth of 4.3% fell short of the consensus estimate of approximately 6%, indicating potential further weakening in the upcoming periods. Additionally, the gross margin for 4Q24 was below expectations, and while guidance anticipates expansion in 2025, it is projected to be significantly less than the 240 basis points achieved in 2024, reducing the company's capacity for reinvestment amidst increasing advertising expenditures. Furthermore, the pet care segment showed softness with organic sales growth of only 2.8%, compounded by adverse volume impacts, and both emerging and developed markets experienced deceleration in growth on a two-year basis, signaling a challenging consumer environment.

Colgate-Palmolive (CL) has been analyzed by 28 analysts, with a consensus rating of Buy. 29% of analysts recommend a Strong Buy, 29% recommend Buy, 36% suggest Holding, 4% advise Selling, and 4% predict a Strong Sell.

This aggregate rating is based on analysts' research of Colgate-Palmolive and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Colgate-Palmolive (CL) Forecast

Analysts have given Colgate-Palmolive (CL) a Buy based on their latest research and market trends.

According to 28 analysts, Colgate-Palmolive (CL) has a Buy consensus rating as of Jul 12, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $93.43, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $93.43, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Colgate-Palmolive (CL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.